年内涨超60%！中欧基金葛兰旗下基金加入“限流”行列

Core Viewpoint - The company announced the suspension of large-scale subscriptions, conversions, and regular investment for the China Europe Medical Innovation Equity Fund starting from August 11, 2025, to ensure stable fund operations and protect the interests of fund shareholders [1]. Fund Overview - The China Europe Medical Innovation Fund was established in February 2019 and primarily invests in stocks related to the medical innovation sector, aiming to achieve returns that exceed the performance benchmark while strictly controlling investment portfolio risks [2]. - As of the end of the second quarter, the fund's scale was 8.114 billion yuan [3]. Performance Metrics - As of August 8, 2025, the annual return of the China Europe Medical Innovation A fund reached 62.28%, ranking 29th among 983 similar funds [4]. Fund Management - The fund is managed by a team led by a manager with a solid research background, who has been with the company since October 2014 and specializes in identifying trends and conducting in-depth company research [5].